Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

NCT02160574 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Surgical Site Infection

Interventions

DRUG: ChloraPrep
DRUG: 0.1% Sodium Lauryl Sulfate
DRUG: 0.9% Physiological Saline
OTHER: ZuraPrep without IPA

Sponsor

Zurex Pharma, Inc.